TME PHARMA Trademark

Trademark Overview


On Thursday, November 3, 2022, a trademark application was filed for TME PHARMA with the United States Patent and Trademark Office. The USPTO has given the TME PHARMA trademark a serial number of 79360076. The federal status of this trademark filing is REGISTERED as of Tuesday, June 25, 2024. This trademark is owned by TME Pharma AG. The TME PHARMA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medicines, medical preparations and medicines for animals, namely, for treating cancer and ophthalmological indications, diagnostic agents for pharmaceutical use; pharmaceuticals and natural remedies, namely, for treating cancer and ophthalmological indications; pharmaceutical compositions, namely, for treating cancer and ophthalmological indications; pharmaceutical preparations, namely, for treating cancer and ophthalmological indications;

Chemicals for use in industry and science, in particular compounds of nucleic acids and derivatives thereof and l-nucleotides and proteins and peptides and derivatives thereof, all for use in the production and development of pharmaceuticals, veterinary and biotechnological products;

Medical services in the field of medicine; medical and clinical examinations; pharmaceutical advice;

Science and technology services, namely, scientific analysis in the field of biotechnology, therapeutics and research and planning services relating to development of pharmaceuticals; medical and pharmacological research services; pharmaceutical research; computer software design; design of databases, design of online databases; computer programming, namely, updating, design and rental of computer software for managing medical patient data, medical teaching and interactive medical simulations; providing online, non-downloadable computer programs and data networks for managing medical patient data, medical teaching and interactive medical simulations; scientific and technological services, namely, scientific analysis in the field of biotechnology, therapeutics and research and design relating thereto in the field of genetic engineering; scientific research for medical purposes and for biochemical use, scientific contract research; research and development of processes, syntheses and dev...
tme pharma

General Information


Serial Number79360076
Word MarkTME PHARMA
Filing DateThursday, November 3, 2022
Status700 - REGISTERED
Status DateTuesday, June 25, 2024
Registration Number7423863
Registration DateTuesday, June 25, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized blue wording 'TME pharma' stacked to the left of a design comprised of a light blue circle containing transparent lines partially surrounded by a light green and blue curved line.
Goods and ServicesMedicines, medical preparations and medicines for animals, namely, for treating cancer and ophthalmological indications, diagnostic agents for pharmaceutical use; pharmaceuticals and natural remedies, namely, for treating cancer and ophthalmological indications; pharmaceutical compositions, namely, for treating cancer and ophthalmological indications; pharmaceutical preparations, namely, for treating cancer and ophthalmological indications;
Indication of Colors claimedThe color(s) blue, green and light blue is/are claimed as a feature of the mark.
Goods and ServicesChemicals for use in industry and science, in particular compounds of nucleic acids and derivatives thereof and l-nucleotides and proteins and peptides and derivatives thereof, all for use in the production and development of pharmaceuticals, veterinary and biotechnological products;
Goods and ServicesMedical services in the field of medicine; medical and clinical examinations; pharmaceutical advice;
NOT AVAILABLETME PHARMA
Goods and ServicesScience and technology services, namely, scientific analysis in the field of biotechnology, therapeutics and research and planning services relating to development of pharmaceuticals; medical and pharmacological research services; pharmaceutical research; computer software design; design of databases, design of online databases; computer programming, namely, updating, design and rental of computer software for managing medical patient data, medical teaching and interactive medical simulations; providing online, non-downloadable computer programs and data networks for managing medical patient data, medical teaching and interactive medical simulations; scientific and technological services, namely, scientific analysis in the field of biotechnology, therapeutics and research and design relating thereto in the field of genetic engineering; scientific research for medical purposes and for biochemical use, scientific contract research; research and development of processes, syntheses and devices for the medical sector and research in the fields of chemistry, biology, biophysics, medicine, biochemistry, genetics, genetic engineering, bacteriology; scientific experiments and analyses; surveying; chemistry services, namely, laboratory research in the field of chemistry, biotechnology, medicine; chemical laboratories; medical laboratory services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, January 13, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 13, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 13, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTME Pharma AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDE

Party NameTME Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE

Party NameTME Pharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events


Event DateEvent Description
Thursday, January 12, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 17, 2023APPLICATION FILING RECEIPT MAILED
Friday, August 18, 2023ASSIGNED TO EXAMINER
Tuesday, August 22, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 23, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 13, 2023REFUSAL PROCESSED BY MPU
Thursday, September 14, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 11, 2023REFUSAL PROCESSED BY IB
Wednesday, February 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, February 29, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, February 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 29, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, February 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 27, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 27, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 15, 2024NOTIFICATION PROCESSED BY IB
Monday, June 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, June 25, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 25, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, December 11, 2024FINAL DISPOSITION PROCESSED
Thursday, December 12, 2024FINAL DISPOSITION NOTICE SENT TO IB
Sunday, January 5, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 21, 2025NEW REPRESENTATIVE AT IB RECEIVED